<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=Windows-1252">
</head>
<body>
<div dir="ltr">
<div></div>
<div>
<div>
<div dir="ltr"></div>
</div>
<div dir="ltr"><br>
</div>
</div>
<div id="id-318418f5-3410-4738-a765-cf1225116fb6" class="ms-outlook-mobile-reference-message">
<div class="WordSection1">
<div>
<p class="MsoNormal"> </p>
</div>
<div align="center">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="100%" id="bodyTable" style="width:100.0%; background:#B9B9B9; border-collapse:collapse">
<tbody>
<tr>
<td width="100%" valign="top" id="bodyCell" style="width:100.0%; padding:15.0pt 15.0pt 15.0pt 15.0pt">
<div align="center">
<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="600" id="templateContainer" style="width:6.25in; border-collapse:collapse; border:none">
<tbody>
<tr>
<td valign="top" style="border:solid #365D9D 2.25pt; border-bottom:none; padding:0in 0in 0in 0in">
<div align="center">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="600" id="templatePreheader" style="width:6.25in; background:#365D9D; border-collapse:collapse; min-width:100%">
<tbody>
<tr>
<td valign="top" style="padding:6.75pt 0in 0in 0in">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%; border-collapse:collapse; min-width:100%">
<tbody>
<tr>
<td valign="top" style="padding:6.75pt 0in 0in 0in">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" align="left" width="100%" style="width:100.0%; border-collapse:collapse; max-width:100%; min-width:100%">
<tbody>
<tr>
<td width="600" valign="top" style="width:6.25in; padding:0in 0in 0in 0in">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" align="left" width="100%" style="width:100.0%; border-collapse:collapse">
<tbody>
<tr>
<td valign="top" style="padding:0in 13.5pt 6.75pt 13.5pt">
<p class="MsoNormal" align="center" style="text-align:center; line-height:125%"><span style="font-size:8.5pt; line-height:125%; font-family:Helvetica; color:white">Email not displaying correctly?
<a href="https://urldefense.com/v3/__https:/mailchi.mp/cprit/cprits-academic-research-program-releases-cycle-212-rfas?e=9416b59a0d__;!!LkSTlj0I!QzNoNgk6hLgMbNqgGoSv7O2zs8i4GKImdKmtfuPHV2FL_Wh0QrRVdUQyiDmeN8sQ$" target="_blank">
<span style="color:white">View it in your browser</span></a> </span></p>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</div>
</td>
</tr>
<tr>
<td valign="top" style="border-top:none; border-left:solid #365D9D 2.25pt; border-bottom:none; border-right:solid #365D9D 2.25pt; padding:0in 0in 0in 0in">
<div align="center">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="600" id="templateHeader" style="width:6.25in; background:white; border-collapse:collapse; min-width:100%">
<tbody>
<tr>
<td valign="top" style="padding:0in 0in 0in 0in">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%; border-collapse:collapse; min-width:100%">
<tbody>
<tr>
<td valign="top" style="padding:6.75pt 6.75pt 6.75pt 6.75pt">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" align="left" width="100%" style="width:100.0%; border-collapse:collapse; min-width:100%">
<tbody>
<tr>
<td valign="top" style="padding:0in 6.75pt 0in 6.75pt">
<p class="MsoNormal" align="center" style="text-align:center"><a href="https://urldefense.com/v3/__https:/texas.us1.list-manage.com/track/click?u=9bc46acc55c4a42d93566d3a5&id=dbca238c67&e=9416b59a0d__;!!LkSTlj0I!QzNoNgk6hLgMbNqgGoSv7O2zs8i4GKImdKmtfuPHV2FL_Wh0QrRVdUQyiMq8j_rB$" title=""" t "><span style="color:windowtext; text-decoration:none"><span style="color:blue"><img border="0" width="270" id="_x0000_i1026" src="https://gallery.mailchimp.com/9bc46acc55c4a42d93566d3a5/images/5a182187-85f2-4aa9-94a5-29122c79320d.png" alt="https://gallery.mailchimp.com/9bc46acc55c4a42d93566d3a5/images/5a182187-85f2-4aa9-94a5-29122c79320d.png" style="width:2.8125in"></span></span></a></p>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</div>
</td>
</tr>
<tr>
<td valign="top" style="border-top:none; border-left:solid #365D9D 2.25pt; border-bottom:none; border-right:solid #365D9D 2.25pt; padding:0in 0in 0in 0in">
<div align="center">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="600" id="templateBody" style="width:6.25in; background:white; border-collapse:collapse; min-width:100%">
<tbody>
<tr>
<td valign="top" style="padding:0in 0in 0in 0in">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%; border-collapse:collapse; min-width:100%">
<tbody>
<tr>
<td valign="top" style="padding:6.75pt 0in 0in 0in">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" align="left" width="100%" style="width:100.0%; border-collapse:collapse; max-width:100%; min-width:100%">
<tbody>
<tr>
<td width="600" valign="top" style="width:6.25in; padding:0in 0in 0in 0in">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" align="left" width="100%" style="width:100.0%; border-collapse:collapse">
<tbody>
<tr>
<td valign="top" style="padding:0in 13.5pt 6.75pt 13.5pt">
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">CPRIT announces the release of six (6) RFAs for the Academic Research program. Complete RFAs and instructions detailing applicable deadlines and requirements are available
in the <a href="https://urldefense.com/v3/__https:/texas.us1.list-manage.com/track/click?u=9bc46acc55c4a42d93566d3a5&id=662b2e02d9&e=9416b59a0d__;!!LkSTlj0I!QzNoNgk6hLgMbNqgGoSv7O2zs8i4GKImdKmtfuPHV2FL_Wh0QrRVdUQyiPLxftUt$" target="_blank">
<span style="color:#47559C">Apply for Funding</span></a> section of <a href="https://urldefense.com/v3/__https:/texas.us1.list-manage.com/track/click?u=9bc46acc55c4a42d93566d3a5&id=b6abc022a7&e=9416b59a0d__;!!LkSTlj0I!QzNoNgk6hLgMbNqgGoSv7O2zs8i4GKImdKmtfuPHV2FL_Wh0QrRVdUQyiP4L4WUE$" target="_blank">
<span style="color:#47559C">CPRIT’s website</span></a>.</span></p>
<ul type="disc">
<li class="MsoNormal" style="color:#606060; line-height:150%; mso-list:l0 level1 lfo1">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif">Core Facility Support Awards (RFA-R 21.2 CFSA)</span></li><li class="MsoNormal" style="color:#606060; line-height:150%; mso-list:l0 level1 lfo1">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif">Clinical Trials Network Award (RFA R-21.2 CTNA)
</span><em><b><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:red">NEW!</span></b></em><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif"></span></li><li class="MsoNormal" style="color:#606060; line-height:150%; mso-list:l0 level1 lfo1">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif">Early Clinical Investigator Award (RFA-R-21.2 ECI)</span></li><li class="MsoNormal" style="color:#606060; line-height:150%; mso-list:l0 level1 lfo1">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif">High Impact/High Risk Research Awards (HIHR) (RFA R-21.2 HIHR)</span></li><li class="MsoNormal" style="color:#606060; line-height:150%; mso-list:l0 level1 lfo1">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif">Texas Clinical Trials Participation Program Award (RFA R-21.2 TCTPA)
</span><strong><i><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:red">NEW!</span></i></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif"></span></li><li class="MsoNormal" style="color:#606060; line-height:150%; mso-list:l0 level1 lfo1">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif">Texas Regional Excellence in Cancer Award (RFA R-21.2 TREC)
</span><em><b><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:red">NEW!</span></b></em><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif"></span></li></ul>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">The application period is September 16, 2020 through January 27, 2021. Proposals must be submitted through CPRIT’s
<a href="https://urldefense.com/v3/__https:/texas.us1.list-manage.com/track/click?u=9bc46acc55c4a42d93566d3a5&id=062f6a1b9d&e=9416b59a0d__;!!LkSTlj0I!QzNoNgk6hLgMbNqgGoSv7O2zs8i4GKImdKmtfuPHV2FL_Wh0QrRVdUQyiDJ_f9rC$" target="_blank">
<span style="color:#47559C">online grant application system</span></a>.</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Core Facility Support Awards (RFA R-21.2-CFSA)
</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060"></span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Solicits applications from institutions to establish or enhance core facilities (laboratory, clinical, population-based, or computer-based) that will directly support
cancer research programs to advance knowledge of the causes, prevention, and/or treatment of cancer or improve quality of life for patients with and survivors of cancer. Institutions may submit 2 applications provided that 1 exclusively supports childhood
cancer research.</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Award:
</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Up to $4,000,000 (total costs); Maximum duration: 5 years.</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Clinical Trials Network Award (RFA R-21.2 CTNA)</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060"></span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">The Clinical Trials Network Award will be made to an institution, organization, or physician group with an established clinical trials infrastructure and clinical trials
portfolio to develop and oversee a network of two cancer care facilities that lack adequate access to clinical trials or sufficient clinical trials infrastructure (stage 1). Once an initial network is satisfactorily demonstrated, the program will be eligible
to expand its network to two additional facilities located outside its current catchment (stage 2).</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Award:</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060"> Up to $600,000 annually for stage 1 and
up to $900,000, annually for stage 2. Maximum duration: 4 years.</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Early Clinical Investigator Award (ECI R-21.2 ECI)</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060"></span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Solicits applications from institutions to provide cancer physicians within the first 3 years of a faculty appointment as an assistant professor the opportunity to
develop clinical research skills and to gain experience in advanced methods and experimental approaches needed to become successful clinical investigators. The award will protect time from clinical responsibilities to allow the early clinical investigator
to develop and conduct investigator initiated clinical trials and to establish a partnership with a laboratory-based collaborator in order to design and conduct correlative studies needed to interpret the outcome of an interventional trial. The overall goal
of this mechanism is to increase the pool of clinical investigators at Texas academic institutions who are conducting patient-oriented studies, capitalizing on basic discoveries and translating them through conduct of innovative clinical trials involving cancer
patients or individuals at risk for cancer. Institutions may submit up to 2 applications.</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Award:
</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Up to $1,500,000 (total costs); Maximum duration: 5 years.</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">High Impact/High Risk Research Awards (RFA R-21.2 HIHR)</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060"></span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Provides short-term funding to explore the feasibility of high-risk projects that, if successful, would contribute major new insights into the etiology, diagnosis,
treatment, or prevention of cancers. Institutions may submit up to 5 applications</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Award:</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060"> Up to $250,000 (total costs); Maximum duration:
2 years.</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Texas Clinical Trials Participation Program Award (RFA R-21.2 TCTPA)</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060"></span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Solicits applications targeting projects to increase the number and diversity of subjects participating in therapeutic cancer clinical trials in Texas by removing non-clinical
out of pocket costs as barriers to participation in cancer clinical trials for financially burdened subjects. Institutions or organizations conducting clinical trials are restricted to 1 application.</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Award:</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060"> Up to $1,500,000 (total costs); Maximum
duration: 3 years.</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Texas Regional Excellence in Cancer Award (RFA R-21.2 TREC)</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060"></span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Solicits applications to strengthen cancer research at institutions located in regions of Texas that have historically received low levels of peer reviewed cancer research
funding. This mechanism is open to Texas institutions whose campus is located > 100 mi from an NCI Designated Cancer Center. The award will support an established investigator to lead a program with a cohesive theme relevant to the cancer problems of the region
and 3 to 5 research projects. In addition, funds maybe requested to support recruitment of new junior faculty, shared resources, and partnerships with established Texas cancer research programs to provide mentorship and access to facilities or expertise.</span></p>
<p class="MsoNormal" style="margin-right:0in; margin-bottom:12.0pt; margin-left:0in; line-height:150%">
<strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Award:
</span></strong><span style="font-size:11.5pt; line-height:150%; font-family:"Georgia",serif; color:#606060">Up to $6,000,000 (total costs); Maximum duration: 5 years.</span></p>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</div>
</td>
</tr>
<tr>
<td valign="top" style="border:solid #365D9D 2.25pt; border-top:none; padding:0in 0in 0in 0in">
<div align="center">
<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="600" id="templateFooter" style="width:6.25in; background:#365D9D; border-collapse:collapse; border:none; min-width:100%">
<tbody>
<tr>
<td valign="top" style="border:none; border-top:solid #365D9D 2.25pt; padding:0in 0in 6.75pt 0in">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%; border-collapse:collapse; min-width:100%">
<tbody>
<tr>
<td valign="top" style="padding:6.75pt 0in 0in 0in">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" align="left" width="100%" style="width:100.0%; border-collapse:collapse; max-width:100%; min-width:100%">
<tbody>
<tr>
<td width="600" valign="top" style="width:6.25in; padding:0in 0in 0in 0in">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" align="left" width="100%" style="width:100.0%; border-collapse:collapse">
<tbody>
<tr>
<td valign="top" style="padding:0in 13.5pt 6.75pt 13.5pt">
<p class="MsoNormal" align="center" style="margin-bottom:12.0pt; text-align:center; line-height:125%">
<em><span style="font-size:8.5pt; line-height:125%; font-family:Helvetica; color:white">Copyright © 2020
<a href="https://urldefense.com/v3/__https:/texas.us1.list-manage.com/track/click?u=9bc46acc55c4a42d93566d3a5&id=155abc8270&e=9416b59a0d__;!!LkSTlj0I!QzNoNgk6hLgMbNqgGoSv7O2zs8i4GKImdKmtfuPHV2FL_Wh0QrRVdUQyiFnv2pgg$" target="_blank">
<span style="color:white">Cancer Prevention and Research Institute of Texas</span></a>, All rights reserved.</span></em><span style="font-size:8.5pt; line-height:125%; font-family:Helvetica; color:white"><br>
<br>
<strong><span style="font-family:Helvetica">Our mailing address is:</span></strong><br>
Cancer Prevention and Research Institute of Texas<br>
PO Box 12097<br>
Austin, Texas 78711<br>
<br>
<a href="https://urldefense.com/v3/__https:/texas.us1.list-manage.com/unsubscribe?u=9bc46acc55c4a42d93566d3a5&id=1092b2dc1b&e=9416b59a0d&c=6bccbf55bc__;!!LkSTlj0I!QzNoNgk6hLgMbNqgGoSv7O2zs8i4GKImdKmtfuPHV2FL_Wh0QrRVdUQyiA-3ONu3$"><span style="color:white">unsubscribe
from this list</span></a> <a href="https://urldefense.com/v3/__https:/texas.us1.list-manage.com/profile?u=9bc46acc55c4a42d93566d3a5&id=1092b2dc1b&e=9416b59a0d__;!!LkSTlj0I!QzNoNgk6hLgMbNqgGoSv7O2zs8i4GKImdKmtfuPHV2FL_Wh0QrRVdUQyiD7t0pNW$">
<span style="color:white">update subscription preferences</span></a> </span></p>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</div>
</td>
</tr>
</tbody>
</table>
</div>
</td>
</tr>
</tbody>
</table>
</div>
<p class="MsoNormal"><img border="0" width="1" height="1" id="_x0000_i1025" src="https://texas.us1.list-manage.com/track/open.php?u=9bc46acc55c4a42d93566d3a5&id=6bccbf55bc&e=9416b59a0d" alt="https://texas.us1.list-manage.com/track/open.php?u=9bc46acc55c4a42d93566d3a5&id=6bccbf55bc&e=9416b59a0d" style="width:.0104in; height:.0104in"></p>
</div>
</div>
<style>@font-face { font-family: Helvetica; }
@font-face { font-family: Wingdings; }
@font-face { font-family: "Cambria Math"; }
@font-face { font-family: Calibri; }
@font-face { font-family: Georgia; }
p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif; }
h1 { margin: 0in 0in 0.0001pt; text-align: center; line-height: 150%; font-size: 22.5pt; font-family: Georgia, serif; color: rgb(193, 135, 0); font-weight: normal; }
h2 { margin: 0in 0in 0.0001pt; text-align: center; line-height: 125%; font-size: 19.5pt; font-family: Helvetica; color: rgb(64, 64, 64); letter-spacing: -0.55pt; font-weight: bold; }
h3 { margin: 0in 0in 0.0001pt; text-align: center; line-height: 125%; font-size: 13.5pt; font-family: Helvetica; color: rgb(96, 96, 96); letter-spacing: -0.4pt; font-weight: bold; }
h4 { margin: 0in 0in 0.0001pt; text-align: center; line-height: 125%; font-size: 12pt; font-family: Helvetica; color: gray; font-weight: bold; }
h5 { margin: 0in 0in 0.0001pt; font-size: 10pt; font-family: Calibri, sans-serif; font-weight: bold; }
h6 { margin: 0in 0in 0.0001pt; font-size: 7.5pt; font-family: Calibri, sans-serif; font-weight: bold; }
p.MsoHeader, li.MsoHeader, div.MsoHeader { margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif; }
p.MsoFooter, li.MsoFooter, div.MsoFooter { margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif; }
a:link, span.MsoHyperlink { color: blue; text-decoration: underline; }
a:visited, span.MsoHyperlinkFollowed { color: purple; text-decoration: underline; }
p.msonormal0, li.msonormal0, div.msonormal0 { margin: 12pt 0in; font-size: 11pt; font-family: Calibri, sans-serif; }
span.Heading1Char { font-family: "Calibri Light", sans-serif; color: rgb(47, 84, 150); }
span.Heading2Char { font-family: "Calibri Light", sans-serif; color: rgb(47, 84, 150); }
span.Heading3Char { font-family: "Calibri Light", sans-serif; color: rgb(31, 55, 99); }
span.Heading4Char { font-family: "Calibri Light", sans-serif; color: rgb(47, 84, 150); font-style: italic; }
span.Heading5Char { font-family: "Calibri Light", sans-serif; color: rgb(47, 84, 150); }
span.Heading6Char { font-family: "Calibri Light", sans-serif; color: rgb(31, 55, 99); }
p.readmsg#id-318418f5-3410-4738-a765-cf1225116fb6, li.readmsg#id-318418f5-3410-4738-a765-cf1225116fb6, div.readmsg#id-318418f5-3410-4738-a765-cf1225116fb6 { margin-right: 0in; margin-left: 0in; font-size: 11pt; font-family: Calibri, sans-serif; }
p.externalclass, li.externalclass, div.externalclass { margin-right: 0in; margin-left: 0in; font-size: 11pt; font-family: Calibri, sans-serif; }
p.mcnimage, li.mcnimage, div.mcnimage { margin-right: 0in; margin-left: 0in; font-size: 11pt; font-family: Calibri, sans-serif; }
p.mcnretinaimage, li.mcnretinaimage, div.mcnretinaimage { margin-right: 0in; margin-left: 0in; font-size: 11pt; font-family: Calibri, sans-serif; }
p.mcntextcontent, li.mcntextcontent, div.mcntextcontent { margin-right: 0in; margin-left: 0in; font-size: 11pt; font-family: Calibri, sans-serif; }
p.mcnpreviewtext, li.mcnpreviewtext, div.mcnpreviewtext { margin-right: 0in; margin-left: 0in; font-size: 11pt; font-family: Calibri, sans-serif; display: none; }
p.mcntextcontent1, li.mcntextcontent1, div.mcntextcontent1 { margin: 12pt 0in; line-height: 125%; font-size: 8.5pt; font-family: Helvetica; color: white; }
p.mcntextcontent2, li.mcntextcontent2, div.mcntextcontent2 { margin: 12pt 0in; line-height: 150%; font-size: 11.5pt; font-family: Georgia, serif; color: rgb(96, 96, 96); }
p.mcntextcontent3, li.mcntextcontent3, div.mcntextcontent3 { margin: 12pt 0in; line-height: 150%; font-size: 11.5pt; font-family: Georgia, serif; color: rgb(96, 96, 96); }
p.mcntextcontent4, li.mcntextcontent4, div.mcntextcontent4 { margin: 12pt 0in; text-align: center; line-height: 125%; font-size: 8.5pt; font-family: Helvetica; color: white; }
span.EmailStyle37 { font-family: Calibri, sans-serif; color: windowtext; }
span.HeaderChar { font-family: Calibri, sans-serif; }
span.FooterChar { font-family: Calibri, sans-serif; }
.MsoChpDefault { font-size: 10pt; }
@page WordSection1 { margin: 1in; }
div.WordSection1 { }
ol { margin-bottom: 0in; }
ul { margin-bottom: 0in; }</style></div>
</body>
</html>